Cite
HARVARD Citation
Solinas, C. et al. (2017). Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of randomized controlled trials. Cancer treatment reviews. pp. 8-15. [Online].